January 17, 2017

Ninth Circuit

Case: In re: Lidoderm Antitrust Litigation
Court: Northern District of California, U.S. District Court Judge William H. Orrick
Drug: Lidoderm, pain patch
Status: Awaiting class certification ruling

This case accusing Endo Pharmaceuticals of paying Watson Pharmaceuticals to delay its launch of a generic version of the lidocaine pain patch is going forward with the bulk of its antitrust claims intact following a battery of largely unsuccessful motions to dismiss in 2014. The judge told both sides after a November hearing that he was inclined to certify a class of indirect purchasers in the case but has not yet ruled on the motions. A jury trial is currently set for December.

The full article can be read here.